Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 6, 209-18

Tinnitus Psychopharmacology: A Comprehensive Review of Its Pathomechanisms and Management

Affiliations

Tinnitus Psychopharmacology: A Comprehensive Review of Its Pathomechanisms and Management

Michele Fornaro et al. Neuropsychiatr Dis Treat.

Abstract

Background: Subjective tinnitus is a frequent, impairing condition, which may also cause neurotransmitter imbalance at the cochlea. Psychopharmacologic agents, although not being the first-line treatment for tinnitus, may modulate cochlear neurotransmission, thereby influencing the subjective tinnitus experience.

Method: A comprehensive review of MEDLINE literature (from January 1990-January 2010) was performed searching for: "tinnitus", major classes of psychopharmacological agents, and psychiatric disorders. The most relevant clinical evidence is reported briefly along with a concise description of the main neurotransmitters purported to be involved in tinnitus, in order to provide the reader with a rational evaluation of tinnitus therapy with psychopharmacological agents.

Results: Although strong methodological issues limit the reliability of the current results, a broad number of psychopharmacological agents have already been considered for tinnitus, both as candidate triggers or potential therapies.

Conclusions: Selected psychopharmacological drugs may play a role in the clinical management of this disorder. While the rational use of these agents for the treatment of tinnitus should not be overlooked, research should be undertaken on their neuromodulating actions at the cochlea.

Keywords: cochlea; psychopharmacology; tinnitus.

Similar articles

See all similar articles

Cited by 10 PubMed Central articles

  • Tinnitus: The Sound of Stress?
    P Ciminelli et al. Clin Pract Epidemiol Ment Health 14, 264-269. PMID 30972125.
    The presence of stress symptoms, measured by ISSL was observed in most of our patients with chronic subjective tinnitus, specially in the resistance and exhaustion phases …
  • Prise en Charge De L’acouphène
    V Wu et al. Can Fam Physician 64 (7), e293-e298. PMID 30002038. - Review
    Les médecins de famille exercent le rôle principal dans la prise en charge des patients souffrant d’un acouphène et ils sont bien placés pour traiter les manifestations t …
  • Approach to Tinnitus Management
    V Wu et al. Can Fam Physician 64 (7), 491-495. PMID 30002023. - Review
    Family physicians play the primary role in managing patients with tinnitus and are well situated to address both the physiologic and the psychological manifestations. As …
  • Vascular Loop in the Cerebellopontine Angle Causing Pulsatile Tinnitus and Headache: A Case Report
    NA Ramly et al. EXCLI J 13, 192-6. PMID 26417253. - Case Reports
    Tinnitus is a common disorder, it can be classified as pulsatile and non-pulsatile or objective and subjective. Pulsatile tinnitus is less common than non-pulsatile and c …
  • Serotonergic Regulation of Excitability of Principal Cells of the Dorsal Cochlear Nucleus
    ZQ Tang et al. J Neurosci 35 (11), 4540-51. PMID 25788672.
    The dorsal cochlear nucleus (DCN) is one of the first stations within the central auditory pathway where the basic computations underlying sound localization are initiate …
See all "Cited by" articles

References

    1. Sequist LV. Protein degradation/chaperone system and histone deacetylase pathway. J Thorac Oncol. 2009;4(11 Suppl 3):S1077–S1078. - PubMed
    1. World Health Organization . International Statistical Classification of Diseases and Related Health Problems; Tenth edition (ICD-10) Geneva, Switzerland: World Health Organization; 1992.
    1. Demeester K, van Wieringen A, Hendrickx JJ, et al. Prevalence of tinnitus and audiometric shape. B-ENT. 2007;3(Suppl 7):37–49. - PubMed
    1. Adoga AA, Adoga AS, Obindo JT. Tinnitus and the prevalence of co-morbid psychological stress. Niger J Med. 2008;17(1):95–97. - PubMed
    1. Sie KC, Rubel EW. Rapid changes in protein synthesis and cell size in the cochlear nucleus following eighth nerve activity blockade or cochlea ablation. J Comp Neurol. 1992;320(4):501–508. - PubMed

LinkOut - more resources

Feedback